Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 21 studies | 35% ± 14% | |
| connective tissue cell | 5 studies | 29% ± 9% | |
| smooth muscle cell | 4 studies | 25% ± 10% | |
| oligodendrocyte | 4 studies | 22% ± 7% | |
| oligodendrocyte precursor cell | 4 studies | 33% ± 9% | |
| myofibroblast cell | 3 studies | 36% ± 7% | |
| adventitial cell | 3 studies | 35% ± 4% |
Insufficient scRNA-seq data for expression of THBS2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 96% | 12060.94 | 439 / 459 | 88% | 88.96 | 979 / 1118 |
| lung | 83% | 5909.51 | 481 / 578 | 80% | 48.33 | 923 / 1155 |
| skin | 100% | 14226.57 | 1802 / 1809 | 59% | 81.39 | 278 / 472 |
| ovary | 100% | 9826.03 | 180 / 180 | 41% | 21.27 | 176 / 430 |
| bladder | 81% | 7436.43 | 17 / 21 | 58% | 32.00 | 290 / 504 |
| uterus | 99% | 14121.42 | 169 / 170 | 39% | 19.56 | 179 / 459 |
| intestine | 68% | 4486.98 | 654 / 966 | 60% | 39.87 | 316 / 527 |
| esophagus | 56% | 2537.32 | 804 / 1445 | 67% | 40.32 | 122 / 183 |
| thymus | 88% | 5474.58 | 575 / 653 | 20% | 5.64 | 121 / 605 |
| blood vessel | 99% | 49489.09 | 1328 / 1335 | 0% | 0 | 0 / 0 |
| brain | 30% | 1000.11 | 789 / 2642 | 69% | 18.51 | 488 / 705 |
| adipose | 98% | 14726.55 | 1178 / 1204 | 0% | 0 | 0 / 0 |
| pancreas | 8% | 338.76 | 25 / 328 | 86% | 108.48 | 153 / 178 |
| stomach | 21% | 1004.62 | 77 / 359 | 68% | 46.92 | 195 / 286 |
| kidney | 35% | 1960.13 | 31 / 89 | 53% | 24.69 | 480 / 901 |
| prostate | 51% | 2657.33 | 126 / 245 | 24% | 6.01 | 120 / 502 |
| heart | 68% | 6476.57 | 587 / 861 | 0% | 0 | 0 / 0 |
| adrenal gland | 45% | 1672.55 | 117 / 258 | 21% | 4.87 | 49 / 230 |
| tonsil | 0% | 0 | 0 / 0 | 51% | 21.02 | 23 / 45 |
| liver | 17% | 834.91 | 39 / 226 | 23% | 7.29 | 93 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 28% | 4.62 | 8 / 29 |
| spleen | 10% | 288.19 | 25 / 241 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 8% | 1.02 | 6 / 80 |
| muscle | 5% | 196.50 | 41 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007155 | Biological process | cell adhesion |
| GO_0051965 | Biological process | positive regulation of synapse assembly |
| GO_0016525 | Biological process | negative regulation of angiogenesis |
| GO_0005604 | Cellular component | basement membrane |
| GO_0031091 | Cellular component | platelet alpha granule |
| GO_0005576 | Cellular component | extracellular region |
| GO_0062023 | Cellular component | collagen-containing extracellular matrix |
| GO_0005201 | Molecular function | extracellular matrix structural constituent |
| GO_0008201 | Molecular function | heparin binding |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | THBS2 |
| Protein name | Thrombospondin-2 Thrombospondin 2 |
| Synonyms | TSP2 |
| Description | FUNCTION: Adhesive glycoprotein that mediates cell-to-cell and cell-to-matrix interactions. Ligand for CD36 mediating antiangiogenic properties. . |
| Accessions | ENST00000617924.6 A0A3B3ITK0 ENST00000649844.1 ENST00000676869.1 A0A7I2V344 A0A7I2YQ86 ENST00000677429.1 ENST00000676760.1 A0A7I2YQT6 A0A7I2V585 Q5RI53 ENST00000366787.7 ENST00000435791.1 ENST00000676628.1 ENST00000676941.1 P35442 ENST00000676498.1 |
